How long can you live taking Everolimus?

Everolimus (Everolimus) is a targeted therapy drug that is an immunosuppressant that inhibits the mTOR (mammalian target of rapamycin) signaling pathway. It is mainly used for immunosuppression after organ transplantation to reduce graft rejection. In addition, everolimus is also used to treat certain types of cancer, such as advanced breast cancer, neuroendocrine tumors, etc.

Clinical trials are an important method to evaluate the efficacy of drugs, but the impact of drugs is multifaceted, including disease progression, survival, quality of life, etc. In some cancer clinical trials, everolimus may have a positive impact on survival in some patients. For example, studies have shown that adding everolimus to patients with advanced breast cancer and neuroendocrine tumors can extend survival. However, these results do not apply to all patients, and effects vary depending on individual circumstances.

It needs to be emphasized that the efficacy and safety of drugs need to be verified through rigorous scientific research and clinical trials. Patients should use everolimus or any other drug under the guidance of a professional physician and undergo regular monitoring and evaluation. The decision whether to use everolimus, as well as the expected therapeutic effects, need to take into account the patient's disease condition, treatment plan, and possible side effects.

Everolimus has been approved for marketing in my country, and has been included in the national medical insurance. The price is about 4000~5000 yuan. It takes about 2 boxes of everolimus per month. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. The cheaper ones abroad are mainly Indian generic drugs, the price is around 700~1,500yuan, and the ingredients of the drugs are basically the same as those in China.